Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03162679
Other study ID # 022ERT
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2017
Est. completion date February 1, 2019

Study information

Verified date April 2019
Source Ludwig-Maximilians - University of Munich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is a lack of studies on treatment effect in traumatised refugees. Recent findings indicate that emotion regulation deficits play a key role in PTSD also among traumatized refugees and highlight the importance and potential directions for the development of an emotion regulation training for refugees. In this study, the investigators therefore want to examine the effectiveness of a new, transdiagnostic, cultural-sensitive group therapy, which systematically teaches specific emotion regulation strategies. Participants will be randomly assigned to either the emotion regulation training, delivered in group format or a wait list control condition. The study takes place in cooperation with REFUGIO Munich, which is a treatment centre specialised in the treatment of traumatised refugees. Clinicians will deliver the treatment to traumatized asylum seekers and refugees that report difficulties in emotion regulation. The investigators will examine if refugees and asylum seekers in the intervention group will show improvements in psychological symptoms, social functioning as well as in emotion regulation in comparison to a wait list control group which will receive the treatment after the intervention group has completed. The group therapy covers 14 sessions and has a cognitive-behavioural background. It focuses on conveying strategies to cope with intense feelings and the patients should gain a sense of self-efficacy and control over their trauma-relevant feelings and symptoms. Qualified interpreters will be used in the assessments as well as group therapies.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date February 1, 2019
Est. primary completion date December 21, 2018
Accepts healthy volunteers No
Gender Male
Age group 15 Years to 21 Years
Eligibility Inclusion Criteria:

- Refugee or asylum seeker from Afghanistan, speaking Dari

- reporting at least one traumatic event on a trauma list

- reporting difficulties in emotion regulation

- between the age of 15 and 21 years

Exclusion Criteria:

- Psychosis

- Serious suicidal ideations

- Currently receiving psychotherapy elsewhere

- Serious dissociation

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Skills training of Affect-Regulation - A culture-sensitive approach: STARK
Emotion Regulation Group Therapy, 14 sessions, 1.5 hour sessions, group therapy, meeting weekly.

Locations

Country Name City State
Germany REFUGIO München Munich

Sponsors (2)

Lead Sponsor Collaborator
Ludwig-Maximilians - University of Munich REFUGIO Munich

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Difficulties in Emotion Regulation Scale: Emotion Regulation Scale (DERS) baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Primary Change in General Health Scale General Health Questionnaire -28 (GHQ-28) baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Secondary Change in posttraumatic stress Scale: PTSD Checklist for DSM-5 (PCL-5) baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Secondary Change in Anger Reactions Scale: Dimensions of Anger Reactions-5 (DAR-5) baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
Secondary Treatment Experience Scale - Patient (TESP) after 14 weeks (= post-treatment)
Secondary Change in emotional competence (Third party assessment by caregiver) Scale: Emotional Competence Questionnaire (German: Emotionale-Kompetenz-Fragebogen - Fremdbeurteilung (EKF)) baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Terminated NCT03781817 - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures Phase 4
Completed NCT04342416 - Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women N/A
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT05669313 - The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Recruiting NCT04725721 - Testing FIRST in Youth Outpatient Psychotherapy N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Not yet recruiting NCT03696563 - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS N/A
Withdrawn NCT03249129 - Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
Completed NCT02240732 - Surgical Tourniquets and Cerebral Emboli N/A
Completed NCT02227979 - Effects of PURPLE Cry Intervention N/A
Withdrawn NCT01169025 - Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients N/A
Recruiting NCT01812941 - Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients N/A
Completed NCT01475344 - Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC) Phase 1/Phase 2
Completed NCT03112304 - Child STEPS for Youth Mental Health in Maine Sustainability N/A
Completed NCT01210417 - Trauma Heart to Arm Time N/A
Completed NCT01201863 - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Phase 4